methylprednisolone hemisuccinate has been researched along with Thrombocytopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krishnan, V; Sen, RK; Tripathy, SK | 1 |
| Aydin, S; Dührsen, U; Nückel, H | 1 |
1 review(s) available for methylprednisolone hemisuccinate and Thrombocytopenia
| Article | Year |
|---|---|
Role of corticosteroid as a prophylactic measure in fat embolism syndrome: a literature review.
Topics: Embolism, Fat; Fever; Fractures, Bone; Humans; Hypoxia; Injections, Intravenous; Meta-Analysis as Topic; Methylprednisolone Hemisuccinate; Purpura; Research Design; Syndrome; Thrombocytopenia; Treatment Outcome | 2012 |
1 trial(s) available for methylprednisolone hemisuccinate and Thrombocytopenia
| Article | Year |
|---|---|
Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin's lymphoma: a single-centre study of 20 patients.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neutropenia; Prognosis; Retrospective Studies; Rituximab; Salvage Therapy; Thrombocytopenia; Treatment Outcome | 2007 |